HTATIP2 and neoplasm: 2.3. Absence of HTATIP2 Expression Promoted Tumor Growth, Decreased Tumor Oxygenation and Reduced Sensitivity to Sorafenib Treatment without Affecting Sorafenib Tumor Distribution